Bicycle Therapeutics

Bicycle Therapeutics is a biotechnology company focused on developing precision-guided therapeutics for solid tumor cancers. Founded in 2009, the company has created a unique therapeutic modality using proprietary molecules known as Bicycles®. These small, cyclized peptides are designed to bind target proteins with high affinity and selectivity, allowing for rapid tumor penetration while minimizing exposure to healthy tissues. The company's mission is to develop impactful medicines that improve patient lives, initially concentrating on oncology and planning to expand into other therapeutic areas such as anti-infective, cardiovascular, and neuromuscular diseases. Bicycle Therapeutics combines small molecules and biopharmaceuticals to create targeted drugs, enhancing safety profiles by ensuring their molecules are eliminated renally. The company primarily serves patients in the United Kingdom and the United States and aims to be a leader in solid tumor treatments through its innovative drug pipeline.